酒精和酒相关的神经障碍:全球视角的当前更新和最近的建议
Prashanti Sahu1, Henu Kumar Verma2, Lvks Bhaskar3
1Department of Zoology, GGU Bilaspur, Bilaspur 495009, Chhattīsgarh, India.
World journal of experimental medicine
|March 21, 2025
概括
酒精使用障碍 (AUD) 会导致严重的神经损伤. 这篇评论详细介绍了AUD的细节.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 遗传学 是一个遗传学.
- 神经学 神经学
背景情况:
- 酒精使用障碍 (AUD) 是一种严重影响中枢神经系统的疾病.
- 神经学并发症包括戒断综合征,韦尼克-科尔萨科夫综合征和痴呆症.
- 了解AUD的神经生物学对于有效治疗至关重要.
研究的目的:
- 探索酒精成的神经生物学基础.
- 审查导致酒风险的遗传因素.
- 详细说明AUD的急性和慢性神经症状.
主要方法:
- 在PubMed,EMBASE,Web of Science和谷歌学者中进行全面的文献搜索.
- 关于神经递质在酒中的作用的研究分析.
- 对遗传研究的审查,包括酒精代谢基因.
主要成果:
- 由于大脑失衡,神经递质如多巴胺,GABA,血清素和谷氨酸都与AUD有关.
- 遗传变异,特别是酒精脱酶1B和脱酶2基因,显著影响酒风险.
- 神经元损伤,营养缺乏和血脑屏障功能障碍有助于AUD的神经问题.
结论:
- AUD涉及复杂的神经生物学和遗传因素.
- 需要对分子机制和神经损伤进行进一步的研究.
- 识别这些机制是未来治疗策略的关键.
相关概念视频
Disorders of the Nervous Tissue
1.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
1.0K
Drug Abuse and Addiction: Pharmacological Phenomena
419
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
419
CNS Depressants: Alcohol and Nicotine
166
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
166
Alzheimer's Disease: Overview
405
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
405
Substance Use Disorders Affecting Sleep
152
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
152
Diagnostic and Statistical Manual of Mental Disorders (DSM)
35
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
35


